ETFs Guizhou Yibai Pharmaceutical Co., Ltd.

600594

CNE000001H03

Pharmaceuticals

End-of-day quote Shanghai S.E. 2026-09-02			5-day change	1st Jan Change
3.970 ^CNY	-4.34%		-2.70%	-0.25%

08-20	Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
04-22	Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

ETFs positioned on Guizhou Yibai Pharmaceutical Co., Ltd.

Name	YTD change	Weight	AuM
VANGUARD FTSE EMERGING MARKETS ALL CAP INDEX ETF - CAD	+13.11%	0%	3,276 M€
VANGUARD FTSE EMERGING MARKETS SHARES ETF - AUD	+4.10%	0%	1,449 M€
VANGUARD FTSE EMERGING MARKETS ETF - USD	+12.68%	0%	126,032 M€
ELM MARKET NAVIGATOR ETF - USD	+9.10%	0%	594 M€
VANGUARD ALL-EQUITY ETF PORTFOLIO - CAD	+15.34%	0%	12,086 M€
VANGUARD FTSE GLOBAL ALL CAP EX CANADA INDEX ETF - CAD	+14.21%	0%	2,612 M€
DEFINED DURATION 20 ETF - USD	+13.88%	0%	19 M€
RPAR RISK PARITY ETF - USD	+5.73%	0%	580 M€
DISCIPLINE FUND ETF - USD	-.--%	0%	73 M€
UPAR ULTRA RISK PARITY ETF - USD	+5.18%	0%	59 M€
VANGUARD CONSERVATIVE ETF PORTFOLIO - CAD	+4.55%	0%	688 M€
VANGUARD BALANCED ETF PORTFOLIO - CAD	+7.83%	0%	4,204 M€
VANGUARD GROWTH ETF PORTFOLIO - CAD	+11.20%	0%	7,793 M€
VANGUARD RETIREMENT INCOME ETF PORTFOLIO - CAD	+2.06%	0%	267 M€
THE BRINSMERE FUND GROWTH ETF - USD	+10.19%	0%	391 M€
CLEARSHARES OCIO ETF - DISTRIBUTING - USD	+8.79%	0%	176 M€
THE BRINSMERE FUND CONSERVATIVE ETF - USD	+4.43%	0%	363 M€
CAMBRIA GLOBAL EW ETF - USD	+9.96%	0%	146 M€
ACTIVEPASSIVE INTERNATIONAL EQUITY ETF - USD	+10.90%	-.--%	1,166 M€
RETURN STACKED GLOBAL STOCKS & BONDS ETF - USD	+10.35%	-.--%	526 M€
ALPHA ARCHITECT US EQUITY 2 ETF - USD	+10.65%	-.--%	513 M€
WARREN STREET GLOBAL EQUITY ETF - USD	+15.06%	-.--%	62 M€
VANGUARD TOTAL INTERNATIONAL STOCK ETF - USD	+15.80%	-.--%	163,510 M€

Guizhou Yibai Pharmaceutical Co Ltd is a China-based company principally engaged in pharmaceutical industry, medical services, and big health industry businesses. The pharmaceutical industry business is mainly engaged in the research and development, production and sales of chemical drugs, traditional Chinese medicines, biological drugs and other drugs. The medical service business is mainly engaged in the operation and management of comprehensive hospitals, tumor specialty hospitals, and tumor radiotherapy centers. The big health industry business is mainly engaged in the development, research, production and sales of big health products featuring Miao medicine. The Company mainly operates its businesses in the domestic market.

Employees

4,832

Sector

Pharmaceuticals

More about the company